Tag: Sangamo stock price analysis

Pfizer Terminates Gene Therapy Deal with Sangamo: Implications for HemophiliaIn a surprising move, Pfizer has decided to halt the development of a hemophilia A gene therapy that it had licensed from Sangamo Therapeutics. This...